Stock Recommendation: IDBI Capital Suggests Buy For Voltas
IDBI Capital suggested a buy for Voltas Ltd. The target price is Rs 1,410 apiece. The stop loss is at Rs 1,343 apiece.
Stock Recommendation: Mirae Asset Suggests Buy For Tata Chemicals
Mirae Asset Alternate Research Head Somil Mehta suggested a buy for Tata Chemicals Ltd. The target price for the stock is Rs 990. The stop loss is at Rs 924.
Stock Market Live Update: UBS On L&T Finance
Maintain Neutral with target price of Rs 210
Q1 business update: In-line AUM growth, beat on disbursement
MFI disbursement grew 10% QoQ indicating favourable mix in Q1 over Q4
Commentary on MFI and asset quality is key
Stock Market Today: Nomura On Bank of Baroda
Maintain Neutral with a target price of Rs 235
Growth trends in both loans and deposits in Q1 were weak
These, coupled with contraction in margins and seasonally soft fee income, are expected to result in a weak core PPOP in Q1
Strong treasury income, led by a 26 bps QoQ decline in G-sec (10-year) yield, should provide some cushion to overall profitability
Stock Recommendation: Macquarie On Tech Mahindra
Maintain Underperform; Hike target price to Rs 1,090 from Rs 1,050
15% EBIT margin target by FY27E a very tough ask
Years of underinvestment in sectors outside Telecom a tough fix
Incumbency a disadvantage for TechM with Telecom clients
15% EBIT margin goal a tough ask, we expect only 12.5-13.5% is achievable
Add Tech Mahindra to Macquarie Marquee Sell ideas
See LTIMindtree as far more attractively positioned
Stock Recommendation: Religare Broking Suggests Buy For LIC Housing Finance
Religare Broking Research Senior Vice President Ajit Mishra suggested a buy for LIC Housing Finance Ltd. The target price for the stock is Rs 630 apiece. The stop loss is at Rs 600 apiece.
Stock Recommendation: Morgan Stanley On Banks
Play the Growth Recovery via the "HIGH FIVE"
Stocks have rallied post-RBI easing measures
FY26 will be tough particularly at banks where there is potential for growth surprise and return of margins to normalized levels
Large private banks and AU Bank are best placed
Expect continued re-rating
A broad-based rally post-RBI easing of liquidity, interest rates and regulations
FY27 would be a confluence of multiple positives
Next two quarters are tough – A buying opportunity
Strong banks will see significant re-rating, we believe
At large private banks, we expect core PPoP CAGR of 16-18% starting in FY27
Stock Recommendation: Mirae Asset Sharkhan Suggests Buy For BSE
Mirae Asset Sharekhan Alternative Research Head Somil Mehta suggested a buy for BSE Ltd. The target price for the stock is Rs 2,950 apiece. The stop loss is at Rs 2,760 apiece.
Stock Recommendation: Macquarie On Tech Mahindra
Maintain Underperform; Hike target price to Rs 1,090 from Rs 1,050
15% EBIT margin target by FY27E a very tough ask
Years of underinvestment in sectors outside Telecom a tough fix
Incumbency a disadvantage for TechM with Telecom clients
15% EBIT margin goal a tough ask, we expect only 12.5-13.5% is achievable
Add Tech Mahindra to Macquarie Marquee Sell ideas
See LTIMindtree as far more attractively positioned
Stock Market Today: Buy Aurobindo Pharma With Target Price Rs 1,240
Religare Broking Research Senior Vice President Ajit Mishra suggested a buy Aurobindo Pharma Ltd. The target price is at Rs 1,240 apiece. The stop loss is at Rs 1,110 apiece.
Stock Market Live: MS On Marico
Maintain Equal-weight with TP of Rs 674
First quarter: Top-line Growth +20%; VAHO Saw Strong Recovery
Demand trends were consistent with improving rural and steady urban
Domestic volume growth continues to see sequential improvement
Gross margin to remain under incremental pressure
Stock Recommendation: InCred On E2E Network
Initiate Add with a target price of Rs 3,245.
E2E is at the trifecta of AI, infrastructure and software platform opportunity
Leading self-service cloud GPU provider at scale
Predictable & affordable pricing, and parentage-led B/S strength provides an early mover advantage
Software – critical to unlock infrastructure price performance
See revenue/EBITDA CAGR of ~60% over FY25-28F driven by monetization of capacity addition and accelerating adoption
Stock Recommendation: Angel One Suggests Buy For Natco Pharma
Angel One Research Senior Vice President suggested a buy for Natco Pharma. The target price is at Rs 1,057. The stop loss is at Rs 917 apiece.
Stock Recommendation: Mehta Equities Suggests Buy For Strides Pharma
Mehta Equities Research Vice President Prashanth Tapse suggested a buy for Strides Pharma Science Ltd. The analyst remains positive about the pharmaceutical sector, expecting positive outcomes from the India–US agreement. Although Strides Pharma has limited presence in the US, its current valuation makes it an appealing investment opportunity.
RECOMMENDED FOR YOU
Market Experts' LIVE Stock Recommendations: Buy, Sell or Hold Today?
Jul 03, 2025
Market Experts' LIVE Stock Recommendations: Buy, Sell or Hold Today?
Jul 02, 2025
Stock Recommendations Today: IndiGo, Dr. Reddy's, Tech Mahindra, Pharma On Brokerages' Radar
Jun 26, 2025
Market Experts' LIVE Stock Recommendations: Hold Garden Reach, Buy Aurobindo Pharma
Jun 18, 2025
POPULAR